Bayoumi AH - Search Results

1

Pharmacophore-linked pyrazolo[3,4-d]pyrimidines as EGFR-TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies.

Gaber AA, El-Morsy AM, Sherbiny FF, Bayoumi AH, El-Gamal KM, El-Adl K, Al-Karmalawy AA, Ezz Eldin RR, Saleh MA, Abulkhair HS. Gaber AA, et al. Among authors: bayoumi ah. Arch Pharm (Weinheim). 2021 Aug 31:e2100258. doi: 10.1002/ardp.202100258. Online ahead of print. Arch Pharm (Weinheim). 2021. PMID: 34467546

2

Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.

Alswah M, Bayoumi AH, Elgamal K, Elmorsy A, Ihmaid S, Ahmed HEA. Alswah M, et al. Among authors: bayoumi ah. Molecules. 2017 Dec 27;23(1):48. doi: 10.3390/molecules23010048. Molecules. 2017. PMID: 29280968 Free PMC article.

3

Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR^WT and EGFR^T790M inhibitors and apoptosis inducers.

Gaber AA, Bayoumi AH, El-Morsy AM, Sherbiny FF, Mehany ABM, Eissa IH. Gaber AA, et al. Among authors: bayoumi ah. Bioorg Chem. 2018 Oct;80:375-395. doi: 10.1016/j.bioorg.2018.06.017. Epub 2018 Jun 12. Bioorg Chem. 2018. PMID: 29986185

4

Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B.

Omar AM, Alswah M, Ahmed HEA, Bayoumi AH, El-Gamal KM, El-Morsy A, Ghiaty A, Afifi TH, Sherbiny FF, Mohammed AS, Mansour BA. Omar AM, et al. Among authors: bayoumi ah. Bioorg Chem. 2020 Mar;96:103656. doi: 10.1016/j.bioorg.2020.103656. Epub 2020 Feb 10. Bioorg Chem. 2020. PMID: 32062449

5

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists.

Ezzat HG, Bayoumi AH, Sherbiny FF, El-Morsy AM, Ghiaty A, Alswah M, Abulkhair HS. Ezzat HG, et al. Among authors: bayoumi ah. Mol Divers. 2021 Feb;25(1):291-306. doi: 10.1007/s11030-020-10070-w. Epub 2020 Mar 12. Mol Divers. 2021. PMID: 32166485

6

Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies.

Abulkhair HS, Turky A, Ghiaty A, Ahmed HEA, Bayoumi AH. Abulkhair HS, et al. Among authors: bayoumi ah. Bioorg Chem. 2020 Jul;100:103899. doi: 10.1016/j.bioorg.2020.103899. Epub 2020 May 17. Bioorg Chem. 2020. PMID: 32454390

7

Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects.

Turky A, Bayoumi AH, Ghiaty A, El-Azab AS, A-M Abdel-Aziz A, Abulkhair HS. Turky A, et al. Among authors: bayoumi ah. Bioorg Chem. 2020 Aug;101:104019. doi: 10.1016/j.bioorg.2020.104019. Epub 2020 Jun 17. Bioorg Chem. 2020. PMID: 32615465

8

Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.

Turky A, Bayoumi AH, Sherbiny FF, El-Adl K, Abulkhair HS. Turky A, et al. Among authors: bayoumi ah. Mol Divers. 2021 Feb;25(1):403-420. doi: 10.1007/s11030-020-10131-0. Epub 2020 Aug 23. Mol Divers. 2021. PMID: 32830299

9

Novel 1,2,4-triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies.

Turky A, Sherbiny FF, Bayoumi AH, Ahmed HEA, Abulkhair HS. Turky A, et al. Among authors: bayoumi ah. Arch Pharm (Weinheim). 2020 Dec;353(12):e2000170. doi: 10.1002/ardp.202000170. Epub 2020 Sep 6. Arch Pharm (Weinheim). 2020. PMID: 32893368

10

Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.

El-Shershaby MH, El-Gamal KM, Bayoumi AH, El-Adl K, Ahmed HEA, Abulkhair HS. El-Shershaby MH, et al. Among authors: bayoumi ah. Arch Pharm (Weinheim). 2021 Feb;354(2):e2000277. doi: 10.1002/ardp.202000277. Epub 2020 Oct 20. Arch Pharm (Weinheim). 2021. PMID: 33078877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page